Zurich Cantonal Bank Portfolio holdings
AUM
$40.9B
1-Year Return
22.88%
This Quarter Return
+10.6%
1 Year Return
+22.88%
3 Year Return
+106.76%
5 Year Return
+189.8%
10 Year Return
+428.78%
AUM
$18.7B
AUM Growth
+$1.83B
(+11%)
Cap. Flow
+$456M
Cap. Flow
% of AUM
2.44%
Top 10 Holdings %
Top 10 Hldgs %
24.05%
Holding
2,988
New
72
Increased
1,595
Reduced
732
Closed
126
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$43.2M |
| 2 |
Eli Lilly
LLY
|
+$41.8M |
| 3 |
Apple
AAPL
|
+$30.3M |
| 4 |
Chevron
CVX
|
+$30.2M |
| 5 |
Eaton
ETN
|
+$27M |
Top Sells
| 1 |
Scotiabank
BNS
|
+$22.4M |
| 2 |
Centene
CNC
|
+$22.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$18.6M |
| 4 |
Cisco
CSCO
|
+$18.6M |
| 5 |
Salesforce
CRM
|
+$18.4M |
Sector Composition
| 1 | Technology | 22.78% |
| 2 | Healthcare | 17.09% |
| 3 | Financials | 16.58% |
| 4 | Industrials | 9.39% |
| 5 | Consumer Discretionary | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Pricesmart
PSMT
$3.41B
| $201K | ﹤0.01% |
3,303
+67
| +2% | +$4.07K |
|
1752
Weis Markets
WMK
$1.73B
| $201K | ﹤0.01% |
2,437
+135
| +6% | +$11.1K |
|
|
RETA
1753
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $200K | ﹤0.01% |
5,276
+791
| +18% | +$30.1K |
|
1754
Rhythm Pharmaceuticals
RYTM
$6.66B
| $200K | ﹤0.01% |
6,879
+691
| +11% | +$20.1K |
|
1755
Herbalife
HLF
$958M
| $200K | ﹤0.01% |
13,454
+737
| +6% | +$11K |
|
1756
CTS Corp
CTS
$1.22B
| $199K | ﹤0.01% |
5,053
+263
| +5% | +$10.4K |
|
1757
Adtran
ADTN
$849M
| $199K | ﹤0.01% |
10,589
+2,244
| +27% | +$42.2K |
|
1758
Eagle Bancorp
EGBN
$596M
| $199K | ﹤0.01% |
4,512
+630
| +16% | +$27.8K |
|
1759
Travere Therapeutics
TVTX
$2.43B
| $198K | ﹤0.01% |
9,432
+1,928
| +26% | +$40.5K |
|
1760
National Bank Holdings
NBHC
$1.47B
| $198K | ﹤0.01% |
4,712
+1,144
| +32% | +$48.1K |
|
1761
Carpenter Technology
CRS
$12.3B
| $198K | ﹤0.01% |
5,366
| – | – |
|
1762
Modine Manufacturing
MOD
$7.95B
| $198K | ﹤0.01% |
9,974
+1,615
| +19% | +$32.1K |
|
1763
Medifast
MED
$152M
| $198K | ﹤0.01% |
1,717
+255
| +17% | +$29.4K |
|
1764
TechTarget
TTGT
$404M
| $198K | ﹤0.01% |
4,488
+992
| +28% | +$43.7K |
|
1765
Tennant Co
TNC
$1.5B
| $198K | ﹤0.01% |
3,210
+478
| +17% | +$29.4K |
|
1766
Procore
PCOR
$10.3B
| $197K | ﹤0.01% |
4,177
+1,025
| +33% | +$48.4K |
|
1767
Ingles Markets
IMKTA
$1.29B
| $197K | ﹤0.01% |
2,042
| – | – |
|
1768
First Commonwealth Financial
FCF
$1.84B
| $197K | ﹤0.01% |
14,082
+2,354
| +20% | +$32.9K |
|
1769
Q2 Holdings
QTWO
$5.13B
| $197K | ﹤0.01% |
7,316
| – | – |
|
1770
Dave & Buster's
PLAY
$796M
| $196K | ﹤0.01% |
5,537
+1,151
| +26% | +$40.8K |
|
1771
NovaGold Resources
NG
$2.84B
| $195K | ﹤0.01% |
32,715
+7,052
| +27% | +$42.1K |
|
1772
Scholastic
SCHL
$660M
| $195K | ﹤0.01% |
4,946
+1,045
| +27% | +$41.2K |
|
1773
Cinemark Holdings
CNK
$3.12B
| $195K | ﹤0.01% |
22,489
+187
| +0.8% | +$1.62K |
|
1774
PRA Group
PRAA
$653M
| $194K | ﹤0.01% |
5,755
+641
| +13% | +$21.7K |
|
1775
Surgery Partners
SGRY
$2.75B
| $194K | ﹤0.01% |
6,977
+2,622
| +60% | +$73K |
|